Sight Sciences (SGHT) Stock Forecast: StockMap's 2-Week Call
SGHT stock forecast: StockMap's model makes no two-week call on Sight Sciences after the Nov 19 close: its evidence is split, 7 reasons for and 8 against. Right in 2 of 3 two-week windows on SGHT since Aug 21; by chance, a call on the same dates was right 69% of the time.
Sight Sciences last closed at $10.62, -1.39% on the session.
Against the IVW growth benchmark the position is +0.94% over the forecast window.
Sight Sciences' market cap is $590.27M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 18 (too close to call).
Where SGHT sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 7 bullish and 8 bearish.
Agreement across those insights is 47%.
11 daily calls for SGHT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Sight Sciences in the 17th percentile on return on equity, where 100 is best.
Sight Sciences is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks Sight Sciences as the 70th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.
On that composite Sight Sciences ranks 5th of 141 in the group, against a group median of -0.18.